editorial for special issue on nasopharynx cancer

1
Editorial Editorial for special issue on Nasopharynx cancer Nasopharynx cancer represents a unique entity in multiple ways; knowledge about its biology, etiology, epidemiology, detec- tion, management, and surveillance have been changing radically and rapidly in the last decade. Nasopharynx cancer remains one of the highest incident malignancies in endemic areas of Southeast Asia, Africa, and in immigrant populations from these geographies. The endemic form of nasopharynx cancer has a recognized viral etiology, Epstein-Barr Virus, and this has been utilized in planning health policy, early detection, treatment stratification, and as a nidus to develop novel therapies. Development of treatment for nasopharynx cancer is one of the greatest success stories. Notwithstanding, management of nasopharynx cancer remains a fine balance between attempts to cure the disease and avoid long-term toxicity, which themselves can be devastating especially given the younger age at presentation for many patients. This issue of Oral Oncology begins a series of special articles on nasopharynx cancer that will encompass a systemic review of etiological factors, DNA damage checkpoints, application of circulating plasma/serum EBV DNA in the clinical management, advances in diagnostic imaging, development of staging system to maximize prognostic accuracy, current controversies in radio- therapy and chemotherapy, surgical salvage of recurrent disease, individualized decision for metastatic disease, current status of no- vel therapies, and translational research for potential new drugs. The special series will be published over the next six issues to give a comprehensive review of the standards of care as well as provide the reader with contemporary research and developments. Ezra Cohen University of Chicago, IL, USA Anne Lee University of Hong Kong-Shenzhen Hospital, Shenzhen, China http://dx.doi.org/10.1016/j.oraloncology.2014.03.005 1368-8375/Ó 2014 Published by Elsevier Ltd. Oral Oncology 50 (2014) 325 Contents lists available at ScienceDirect Oral Oncology journal homepage: www.elsevier.com/locate/oraloncology

Upload: anne

Post on 30-Dec-2016

216 views

Category:

Documents


3 download

TRANSCRIPT

Oral Oncology 50 (2014) 325

Contents lists available at ScienceDirect

Oral Oncology

journal homepage: www.elsevier .com/locate /ora loncology

Editorial

Editorial for special issue on Nasopharynx cancer

http://dx.doi.org/10.1016/j.oraloncology.2014.03.0051368-8375/� 2014 Published by Elsevier Ltd.

Nasopharynx cancer represents a unique entity in multipleways; knowledge about its biology, etiology, epidemiology, detec-tion, management, and surveillance have been changing radicallyand rapidly in the last decade. Nasopharynx cancer remains oneof the highest incident malignancies in endemic areas of SoutheastAsia, Africa, and in immigrant populations from these geographies.The endemic form of nasopharynx cancer has a recognized viraletiology, Epstein-Barr Virus, and this has been utilized in planninghealth policy, early detection, treatment stratification, and as anidus to develop novel therapies. Development of treatmentfor nasopharynx cancer is one of the greatest success stories.Notwithstanding, management of nasopharynx cancer remains afine balance between attempts to cure the disease and avoidlong-term toxicity, which themselves can be devastating especiallygiven the younger age at presentation for many patients.

This issue of Oral Oncology begins a series of special articles onnasopharynx cancer that will encompass a systemic review of

etiological factors, DNA damage checkpoints, application ofcirculating plasma/serum EBV DNA in the clinical management,advances in diagnostic imaging, development of staging systemto maximize prognostic accuracy, current controversies in radio-therapy and chemotherapy, surgical salvage of recurrent disease,individualized decision for metastatic disease, current status of no-vel therapies, and translational research for potential new drugs.The special series will be published over the next six issues to givea comprehensive review of the standards of care as well as providethe reader with contemporary research and developments.

Ezra CohenUniversity of Chicago, IL, USA

Anne LeeUniversity of Hong Kong-Shenzhen Hospital,

Shenzhen, China